机构:[1]Division of Nephrology, Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen, Fujian 361000[2]Division of Nephrology, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong 510405深圳市中医院深圳医学信息中心[3]Division of Nephrology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China
Lupus nephritis (LN) occurs in ~50% of patients with systemic lupus erythematosus and is a major cause of morbidity and mortality of the affected individuals. Therefore, identification of novel and predictive biomarkers for the early diagnosis and progression of LN is required. The present study included 10 patients with LN whose diagnoses were confirmed by renal biopsy and 5 healthy participants as control subjects. Sera were collected both from patients with LN and healthy controls. Subsequently, mesangial cells were treated with these sera for 24 h. Differential proteins between groups were detected by two-dimensional difference gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time of flight mass spectrometry analysis. 2D-DIGE maps of cellar proteins were obtained for LN and normal control groups. A total of 45 proteins were characterized, and 2 low-abundance proteins were identified. Compared with the normal human sera group, expression level of Annexin A2 was elevated in patients with LN, while the expression of the ferritin heavy chain (FTH1) decreased in the LN group; the analysis was carried out by DeCyder version 7.0 automatically. The results of the present study suggest that Annexin A2 and FTH1 contributed to the progression of LN and could serve as potential biomarkers for this disease.
基金:
The present study was supported by a grant from the National Science Foundation of China (grant no. 81600531), the Fujian Provincial Science Foundation (grant no. 2017J01371) and Fujian Provincial Health and Family Planning Program for Young and Middle-Aged Talents Project (grant no. 2017-ZQN-92).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|4 区医学
小类|4 区医学:研究与实验
最新[2025]版:
大类|4 区医学
小类|4 区医学:研究与实验
第一作者:
第一作者机构:[1]Division of Nephrology, Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen, Fujian 361000[2]Division of Nephrology, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong 510405
共同第一作者:
通讯作者:
通讯机构:[2]Division of Nephrology, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong 510405[3]Division of Nephrology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian 361004, P.R. China[*1]Division of Nephrology, First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, 16 Jichang Road, Guangzhou, Guangdong 510405, P.R. China[*2]Division of Nephrology, Zhongshan Hospital Affiliated to Xiamen University, 203 Hubin South Road, Xiamen, Fujian 361004, P.R. China
推荐引用方式(GB/T 7714):
YANNI ZHOU,LIANGXIANG XIAO,SHUIFU TANG.Annexin A2 and FTH1 are potential biomarkers for lupus nephritis.[J].Experimental and therapeutic medicine.2018,16(5):3766-3776.doi:10.3892/etm.2018.6686.
APA:
YANNI ZHOU,LIANGXIANG XIAO&SHUIFU TANG.(2018).Annexin A2 and FTH1 are potential biomarkers for lupus nephritis..Experimental and therapeutic medicine,16,(5)
MLA:
YANNI ZHOU,et al."Annexin A2 and FTH1 are potential biomarkers for lupus nephritis.".Experimental and therapeutic medicine 16..5(2018):3766-3776